U.S. Water Utilities Stock News

Kennametal overview and recent share performance Kennametal (KMT) has attracted attention after a strong run in its shares, with the stock recently closing at US$38.98 and posting positive returns over the past month, the past 3 months, and year to date. See our latest analysis for Kennametal. Beyond the recent move to US$38.98, Kennametal’s 30 day share price return of 9.40% and year to date share price return of 34.46% sit alongside a 1 year total shareholder return of 110.97%. Together,...

If you are wondering whether DXC Technology at around US$12.82 is a bargain or a value trap, the starting point is understanding what the current market price is implying about its future. The stock has returned 1.5% over the last 7 days and 5.7% over the last 30 days. Yet year to date it is down 8.9% and over 1 year the return is a 15.4% decline, with 3 and 5 year returns of 43.9% and 59.8% decline respectively. Recent headlines around DXC have focused on its position in the IT services...

Investors may be wondering whether Comfort Systems USA at around US$1,724.49 is still offering value, or if most of the easy gains are already behind it. The stock has posted returns of 4.6% over 7 days, 22.5% over 30 days, 71.8% year to date and very large multi-year gains, including about 12x over 3 years and more than 20x over 5 years. Recent coverage has focused on Comfort Systems USA as a construction and building services provider that has attracted attention following its strong...

Tripadvisor (NasdaqGS:TRIP) has entered a cooperation agreement with activist investor Starboard Value. The deal gives Starboard immediate and upcoming representation on Tripadvisor’s board of directors. The board plans to review options for a potential sale of the company and for Tripadvisor’s restaurant booking unit, TheFork. For you as an investor, this puts fresh attention on Tripadvisor’s core role as a travel reviews and booking platform and on TheFork as a separate, restaurant...

What Jabil’s Recent Share Move Tells You Jabil (JBL) has attracted attention after a strong recent share move, with the stock showing double digit returns over the past month and past 3 months. For investors, the question is how that performance lines up with the company’s current fundamentals. See our latest analysis for Jabil. Beyond the recent surge, Jabil’s 30 day share price return of 26.34% and 90 day share price return of 37.47% sit alongside a very large 5 year total shareholder...

Why Viking Therapeutics (VKTX) Is Back on Watchlists Viking Therapeutics (VKTX) has drawn renewed attention after recent share price moves. The stock closed at US$34.25 and has shown mixed performance over the past week, month, and past 3 months. See our latest analysis for Viking Therapeutics. The recent 1 day share price return of 1.33% and 30 day share price return of 5.22% sit against a year to date share price decline of 3.30%, while the 1 year total shareholder return of 32.80% and 5...

The U.S. fiscal 2027 budget proposal points to a sharp rise in Space Force spending on satellite communications and missile defense, putting Intuitive Machines (LUNR) and its Lanteris subsidiary squarely in focus for potential defense contracts. See our latest analysis for Intuitive Machines. Intuitive Machines has seen strong momentum recently, with a 1-day share price return of 7.62%, a 30-day share price return of 47.42%, and a 1-year total shareholder return of 280.92%, as investors react...

Kinsale Capital Group (KNSL) has drawn investor attention after recent share price swings, including a 2.6% move lower over the past day, set against mixed returns over the month and the past 3 months. See our latest analysis for Kinsale Capital Group. Looking beyond the recent 1 day share price decline, Kinsale Capital Group’s 30 day share price return of 6.54% contrasts with a 90 day share price return of 14.22% and a 1 year total shareholder return decline of 28.78%. This suggests momentum...

Wondering if StoneCo at US$15.08 is offering value or simply treading water? This breakdown will help you size up the stock before you commit new capital. The share price shows mixed signals, with a 1.1% return over the last 7 days, 7.3% over 30 days, 2.7% year to date, 15.7% over 1 year, 28.7% over 3 years, but a 78.3% decline over 5 years. Recent coverage around StoneCo has focused on how the stock's long term pullback and more recent positive returns have shifted sentiment among investors...

If you are wondering whether TriMas is still attractively priced after a strong run, this breakdown will help you see how the current share price lines up with several valuation checks. The stock closed at US$36.18, with returns of 2.5% over 30 days, a 0.3% decline year to date, and 73.2% over the last year, which has put the question of value and risk front and center for many investors. Recent coverage around TriMas has focused on its position in the packaging and materials space and how...

If you are wondering whether Colgate-Palmolive at around US$82 per share offers fair value or a potential mispricing, the key is to look past the brand name and into what the current market price actually reflects. The stock has eased back recently, with a 1.4% decline over the last 7 days and a 3.3% decline over the last 30 days, even though the year to date return sits at 6.0% and the 1 year return is 10.1% lower. These moves sit against a broader backdrop of ongoing interest in defensive...

Hayward Holdings stock snapshot after recent performance swings Hayward Holdings (HAYW) has seen mixed share performance recently, with a 1 day pullback, a gain over the past week and month, and a decline across the past 3 months and year to date. See our latest analysis for Hayward Holdings. While the latest share price of US$15.16 sits below recent highs, the 30 day share price return of 9.46% contrasts with a 90 day decline of 9.38% and a 1 year total shareholder return of 21.28%. This...

If you are wondering whether Quest Diagnostics at around US$204 is offering solid value or asking too much, you are in the right place for a closer look at what that price actually reflects. The stock has recorded returns of 6.6% over the last 7 days, 4.3% over 30 days, 17.4% year to date, 19.7% over 1 year, 47.5% over 3 years and 70.8% over 5 years. Recent price action is therefore an important part of the valuation story. Recent news coverage has focused on Quest Diagnostics as a key...

Why Rumble’s latest cloud and AI moves matter for shareholders Rumble (RUM) has been reshaping its business with a series of product, advertising, and cloud-related updates, giving you more to assess than just its video platform roots. The recent quarter highlighted continued spending on platform stability, monetization tools, and short-form video, with Rumble Shorts passing one million daily unique video views and Rumble Wallet adding a crypto earnings option for creators. Alongside this,...

Wondering if Garmin's share price still offers value after a strong run, or if most of the upside is already priced in? This article focuses squarely on what you are getting for the price you pay. Garmin recently closed at US$266.59, with returns of 0.3% over 7 days, 11.7% over 30 days, 31.7% year to date, 39.8% over 1 year, 196.4% over 3 years and 116.1% over 5 years, which puts the current valuation front and center for anyone considering the stock today. Recent coverage around Garmin has...

Before getting into the details, start by asking a simple question: at around US$26.95 per share, does Compass Minerals International look attractively priced, or is the recent enthusiasm already reflected in the stock? Recent returns have been strong, with the share price showing gains of 8.6% over the last 7 days, 18.2% over 30 days, 35.7% year to date, and 125.7% over the past year, even though the 3 year and 5 year returns sit at 13.1% and 58.6% declines respectively. This combination of...

Euronet Worldwide (EEFT) is drawing fresh attention after announcing an Investor Day on Wednesday, May 20, 2026. At the event, management plans to outline its strategic vision, business segment priorities, and financial outlook. See our latest analysis for Euronet Worldwide. The recent momentum around the Investor Day announcement sits against a mixed performance backdrop, with a 30 day share price return of 17.29% but a 1 year total shareholder return decline of 18.57%. This suggests...

Rambus Inc. recently launched its SOCAMM2 chipset, enabling low-power, high-performance LPDDR5X-based, JEDEC-standard memory modules for AI server platforms with enhanced control, telemetry, and localized power delivery. By replacing soldered LPDDR with detachable, serviceable SOCAMM2 modules, Rambus is promoting a more flexible, upgradable memory architecture for demanding AI data centers. We’ll now examine how Rambus’s SOCAMM2 LPDDR5X server chipset expansion into modular AI memory could...

If you are wondering whether Novavax's current share price reflects its true worth, this article walks through what that value might look like using several common yardsticks. The stock most recently closed at US$8.45, with a 7 day return of a 2.8% decline, a 30 day return of a 13.1% decline, but gains of 18.5% year to date and 13.1% over the past year. This combination can hint at shifting views on both risk and potential. Recent headlines around Novavax have focused on its position in the...

If you are wondering whether Harmony Biosciences Holdings is priced attractively today, the key question is whether the current share price reflects its underlying fundamentals or if the market is mispricing the stock. The share price last closed at US$31.97, with recent returns of 9.4% over 7 days, 15.8% over 30 days, 10.6% over 1 year and a negative 14.5% return year to date. This may signal changing views on both potential and risk. Recent company specific news has kept Harmony...

Tempus AI (NasdaqGS:TEM) announced a new partnership with the Keck School of Medicine of USC and Keck Medicine of USC. The agreement covers integration of Tempus molecular diagnostics across a major Southern California healthcare network. The collaboration includes automation of clinical trial matching and AI driven support for care gap closure. The partners plan joint research and diagnostic co development tied to more than 1.5 million annual patient visits. For readers tracking healthcare...

Ares Management (NYSE:ARES) has announced key leadership appointments in Asia to grow its Asia Credit and Special Situations platform. E.G. Morse, previously at Goldman Sachs, has been appointed Partner and Head of Asia Credit. A new leadership structure has been created for the Asia Special Situations strategy, focused on expanding the firm’s regional presence. Ares Management is a global alternative investment manager with businesses across credit, private equity, real assets and related...

Danaher (NYSE:DHR) has launched a major euro-denominated debt offering of nearly €3b in senior notes. The financing is intended to help fund Danaher’s pending acquisition of Masimo Corporation. The senior notes have been priced and are expected to close in the near term. Danaher operates across life sciences, diagnostics and related technologies, and the planned acquisition of Masimo would expand its presence in patient monitoring and medical devices. By turning to euro-denominated senior...

Reliance (RS) is back in focus after first quarter 2026 earnings, with sales of US$4,026 million and net income of US$264.9 million, alongside higher earnings per share compared with a year earlier. See our latest analysis for Reliance. The earnings release has been followed by a sharp move in the share price, with a 1-day share price return of 4.43%, a 7-day return of 9.68% and a 30-day return of 20.26%. This builds on a 1-year total shareholder return of 26.03% and suggests momentum has...